| First Author | Jiang S | Year | 2011 |
| Journal | Blood | Volume | 117 |
| Issue | 3 | Pages | 827-38 |
| PubMed ID | 21063029 | Mgi Jnum | J:168507 |
| Mgi Id | MGI:4888464 | Doi | 10.1182/blood-2010-01-265082 |
| Citation | Jiang S, et al. (2011) Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood 117(3):827-38 |
| abstractText | Endocannabinoids are arachidonic acid derivatives and part of a novel bioactive lipid signaling system, along with their G-coupled cannabinoid receptors (CB and CB) and the enzymes involved in their biosynthesis and degradation. However, their roles in hematopoiesis and hematopoietic stem and progenitor cell (HSPC) functions are not well characterized. Here, we show that bone marrow stromal cells express endocannabinoids (anandamide and 2-arachidonylglycerol), whereas CB receptors are expressed in human and murine HSPCs. On ligand stimulation with CB agonists, CB receptors induced chemotaxis, migration, and enhanced colony formation of bone marrow cells, which were mediated via ERK, PI3-kinase, and Galphai-Rac1 pathways. In vivo, the CB agonist AM1241 induced mobilization of murine HSPCs with short- and long-term repopulating abilities. In addition, granulocyte colony-stimulating factor -induced mobilization of HSPCs was significantly decreased by specific CB antagonists and was impaired in Cnr2(-/-) cannabinoid type 2 receptor knockout mice. Taken together, these results demonstrate that the endocannabinoid system is involved in hematopoiesis and that CB/CB agonist axis mediates repopulation of hematopoiesis and mobilization of HSPCs. Thus, CB agonists may be therapeutically applied in clinical conditions, such as bone marrow transplantation. |
